Ticker Scorecard - DSGN Basics Company: Design Therapeutics, Inc. IPO Date: March 29, 2021 Sector: Healthcare Industry: Biotech Market Cap: $278.01M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.47% Avg Daily Range (30 D): $0.22 | 4.72% Avg Daily Range (90 D): $0.23 | 4.15% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .14M Avg Daily Volume (90 D): .13M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 264 Avg Inst. Trade: $1.65M Avg Inst. Trade (30 D): $.64M Avg Inst. Trade (90 D): $1.01M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.38M Avg Closing Trade (30 D): $1.7M Avg Closing Trade (90 D): $1.7M Avg Closing Volume: 186.59K     News May 7, 2024 @ 10:30 AM Design Therapeutics to Participate in the 2024 RBC... Source: Design Therapeutics, Inc. Mar 26, 2024 @ 11:37 AM Design Therapeutics And 2 Other Stocks Under $5 In... Source: Avi Kapoor Mar 19, 2024 @ 8:01 PM Design Therapeutics Outlines Progress Across GeneT... Source: Design Therapeutics, Inc. Mar 12, 2024 @ 10:30 AM Design Therapeutics to Webcast Fourth Quarter and ... Source: Design Therapeutics, Inc. Dec 18, 2023 @ 5:00 PM Design Therapeutics, Inc. (DSGN) Upgraded to Buy: ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.85 $-.23 $-.21 Diluted EPS $-.85 $-.23 $-.21 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -47.78M $ -13.04M $ -11.79M Operating Income / Loss $ -60.81M $ -16.25M $ -15.04M Cost of Revenue $ $ $ Net Cash Flow $ 2.39M $ -15.37M $ 16.3M PE Ratio